Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Boehringer-Ingelheim Pharmaceuticals, Inc.
Lobbying Relationship
Bills mentioned
H.R.4899: Supplemental Appropriations Act, 2010
Sponsor: David R. Obey (D-Wis.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Jennifer Bell | Senate Finance Committee - Health Policy Advisor Rep. John Thune (R-SD) - Legislative Assistant Legislative Assistant, Rep. John Thune (R-SD) Health Policy Advisor, Sen. Finance Committee |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Registration
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate